Target Healthcare REIT (LSE:THRL) Tariff Resilience Score: 0/10 (As of Jul. 04, 2026)


LSE:THRL Target Healthcare REIT PLC LSE:THRL
36 GF Score
Price £1.10
GF Value £0.88
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Target Healthcare REIT Tariff Resilience Score?

Target Healthcare REIT has the Tariff Resilience Score of 0, which implies that the company might have .

Target Healthcare REIT has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Target Healthcare REIT might have .

Target Healthcare REIT  (LSE:THRL) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Target Healthcare REIT Tariff Resilience Score Related Terms

LSE:THRL
36GF Score
Target Healthcare REIT PLC LSE:THRL
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Target Healthcare REIT (LSE:THRL) Overvalued in 2026?

Based on GuruFocus' analysis, Target Healthcare REIT stock appears to be overvalued. The current stock price of £1.10 is trading 25% above its estimated GF Value™ of £0.88. GuruFocus considers Target Healthcare REIT to be Modestly Overvalued.

Key valuation signals for LSE:THRL:

  • Tariff Resilience Score: 0
  • GF Value™: £0.88 vs. price of £1.10 (25% above fair value)
  • GF Score™: 36/100 with 7 warning signs

No single metric tells the full story. See the LSE:THRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Target Healthcare REIT Business Description

Industry Real EstateREITs
Address 69 Old Broad Street, Level 4, Dashwood House, London, GBR, EC2M 1QS
Target Healthcare REIT PLC is an investment company that acts as a long-term investor in care homes in the United Kingdom. The investment objective of the company is to provide shareholders with an attractive level of income together with the potential for capital and income growth from investing in a diversified portfolio of freehold and long-leasehold care homes, which are let to care home operators, and other healthcare assets in the United Kingdom.
36GF Score

Get the complete analysis for LSE:THRL

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£1.10
Price
£0.88
GF Value